Daily Dispatch

The 'Dispatched' Podcast

News EN ↓ 209 episodes

BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

Be sure to visit the podcast's website and support the creator: bpd.captivate.fm

Author

Daily Dispatch

Category

News

Podcast website

bpd.captivate.fm

Latest episode

Nov 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

The 'Week in Review' - 1 December 01.12.2023

We discuss the apparent reluctance to speak out on one important issue. The Government's entirely predictable response to the inquiry on access to new medicines and novel medical technologies, why disappointment is the wrong reaction, and the importance of giving New Zealand's government time to reform Pharmac.

The 'Week in Review' - 24 November 23.11.2023

The power of language and the habit governments have of weaponising the word 'sustainable'. How the term has been used to 'gently' justify breaking election commitments and its wider impact on policy development and change.

The 'Week in Review' - 17 November 16.11.2023

Some interesting undertones at the Pharmacy Guild's annual parliamentary dinner, a  slow start to 60-day dispensing and whether the plan for a new agreement to be in place by 1 March is realistic. The industry is very effective at advocacy, but not in the way it might think or hope, and the weight loss therapies that have system-shaping implications.

The 'Week in Review' - 10 November 10.11.2023

Any nominations for the 'It Seemed Like a Good Idea at the Time' award? The opportunity to shift the current strategic alignments that impact decision-making, the challenge of diagnosis and why the existing decision-making framework makes it inevitable.

The 'Week in Review' - 3 November 03.11.2023

The 'inner circle' running the HTA review and the obsession with confidentiality. An invitation for the government to launch preemptive action to prevent the publication of information that could meet the 'confidentiality' criteria and the least surprising outcome of 2023.

The 'Week in Review' - 27 October 27.10.2023

Strange accounting in the health department's annual report with 'adjustments and notional entries required for presentation only' bumping the PBS spend by $1.2 billion. What does it mean? History matters when it comes to policy, with almost nothing happening that the industry did not negotiate, including the time taken to list recommended medicines. This is why the lessons of histo...

The 'Week in Review' - 20 October 20.10.2023

Genomics and this week's CanForum, at which Rare Cancers Australia hosted several interesting discussions, particularly highlighting the patient experience and the federal government's desultory plan for an 'advisory committee'. Should the result of last weekend's referendum trigger a rethink by organisations that actively supported the proposed change?

The 'Week in Review' - 13 October 13.10.2023

We discuss this week's interview with the HTA review reference committee chair and answer your questions, including whether the denigration of a journalist and patients is unique to New Zealand's Pharmac and why annual elections for industry association boards might be a bad idea.

The Dispatched Podcast - Your Questions 10.10.2023

Not all listeners were happy with our suggestion the current health technology assessment review is not the first 'comprehensive' process in the past 30 years. We are answering that question and have produced a list of between 40 and 50 similar processes since 1993.  It matters because it provides valuable lessons and demonstrates the connection between a review in 2023 and previous proc...

The 'Week in Review' - 6 October 05.10.2023

This week's podcast discusses what history tells us about the pre-conditions for change driven by non-government stakeholders - there are few. Are these pre-conditions evident today, or will another policy process end badly? Importantly, there is a way forward in an exclusionary process shrouded in secrecy, but history counts because it provides all the lessons.

The 'Week in Review' - 1 October 01.10.2023

A  special week in review recorded in New Zealand with election candidate and former industry executive Todd Stephenson. We were lucky to join Mr Stephenson and ACT leader David Seymour on the campaign trail in Wanaka and Queenstown. We discuss the range of issues impacting the election, including the political and policy focus on Pharmac.

The 'Week in Review' - 22 September 22.09.2023

A special guest joins the podcast to discuss the lost opportunity to celebrate a significant anniversary for the PBS and even reshape perceptions of the program. The government has also released its Final Budget Outcome, revealing strong growth in pharmaceutical spending and a problem with invoicing companies for rebates.

The 'Week in Review' - 15 September 15.09.2023

The entitlement challenge, secret policy processes, and why they matter. We also discuss why Budget forecasts for PBS spending have minimal use - what matters is the actual spend that reflects the addition of new medicines - and how the combination of events has become an indicator of change.

The 'Week in Review' - 8 September 07.09.2023

Two PBS 'demonstrations' in Canberra this week -  different tones but the messages were basically the same. The complex period ahead for the PBS is reflected across the health portfolio. The raft of reviews launched by the Albanese Government since its election will start to land containing a raft of recommendations that could trigger fierce fights between stakeholder groups.

The 'Week in Review' - 1 September 01.09.2023

What are the wider implications of the negotiation for a new Community Pharmacy Agreement, to take effect on 1 March 2024, and can another secret policy process deliver for patients? Another managed release of information on the international HTA collaboration reveals an additional 'fragment' on its activities.

The 'Week in Review' - 25 August 24.08.2023

The 2023 IGR has reinforced the longstanding isolation of Budget investment in health and new therapeutic technologies as 'costs' that must be managed. It has also acknowledged the challenge of forecasting future spending beyond the short term. We discuss how the IGR and its focus on investment in health as a cost will frame the raft of current review processes.

The 'Week in Review' - 18 August 18.08.2023

This week's discussion concerns transparency, or the lack of in policy development processes, and how it leads to highly curated outcomes that rarely benefit public health programs and the people they are designed to serve.

The 'Week in Review' - 11 August 10.08.2023

We discuss what has been a hectic week, to say the least, where to from here, and the implications against the backdrop of a complex and highly uncertain period ahead.

The 'Week in Review' - 4 August 04.08.2023

This week in review is titled 'you can't make this up' as we focus on the lack of transparency and openness on two critical processes and the excuses to justify the secrecy. We also discuss interesting news about the 16 referrals for potential breaches of the APS Code of Conduct following the release of the robodebt royal commission report.

The 'Week in Review' - 28 July 28.07.2023

We answer your questions today, with each of us producing our own list of five positive things about the PBS, but also the opportunities for reform. 

The 'Week in Review' - 21 July 21.07.2023

New Zealand's Pharmac looks forward to sharing its model with counterparts in Australia, the UK and Canada, the parliament is considering new laws that will force one group of families into a very difficult and unfair decision that could have implications for every patient advocate, the government has released its long-awaited 'well-being index', and we answer your questions.

The 'Week in Review' - 14 July 14.07.2023

Why should everyone be concerned by the obsession with secrecy over a public health program, the wider lessons from the 'Royal Commission into the Robodebt Scheme', and the reality that a status quo approach to policy change is doomed to fail?

The 'Week in Review' - 7 July 06.07.2023

The secret involvement of Pharmac in the international HTA collaboration, why it has no place in any process that could impact patients anywhere in the world, and why industry and patients need to act to urgently block the 'dark arts' spread of its terrible ideas.

The 'Week in Review' - 30 June 30.06.2023

Why are some people so sensitive to criticism of health technology assessment? What does it reveal about the decision-making culture, and why must it be confronted? Tomorrow will see a long-awaited change for one group of marginalised patients. What does it mean, why is it important, and what does it reveal and the challenge of advocacy and securing change?

The 'Week in Review' - 23 June 23.06.2023

Health technology assessment and why systems have it so wrong when it comes to patients and decision-making. The latest on the reform of the Opiate Dependence Treatment Program and why the compulsory acquisition of a hospital in Canberra highlights everything wrong with policy development.

Listen to the The 'Dispatched' Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.